Author: Staff

Andrew Gitkind, MD, vice chairman and medical director of New York City-based Montefiore Spine Center, outlines the department's recent growth and its goals for the coming year.

Jason E. Lowenstein, MD, director of the Scoliosis and Spinal Deformity Center at Morristown, N.J.-based Atlantic Health System, discusses the department's goals to expand treatment options in the future.

Here are nine spine and neurosurgeons making headlines.

The global spinal implants market is expected to grow at a 5.5 percent compound annual growth rate between 2017 and 2023, according to a Market Research Future report.

Gender is not associated with surgical outcomes after minimally invasive transforaminal lumbar interbody fusion, according to a study in Clinical Spine Surgery.

Douglas Orndorff, MD, is a board-certified orthopedic spine surgeon at Durango-based Spine Colorado.

Irvine, Calif.-based Hoag Orthopedic Institute researchers analyzed 102 simple knee arthroscopy cases and found opioid prescriptions exceed what is necessary for postoperative pain management. Study authors published their results in The Journal of Bone and Joint Surgery.

OSF HealthCare Medical Group in Kewanee, Ill., welcomed Peter J. Mulhern, MD.

There were 63,632 American drug overdose deaths in 2016, and 66 percent involved an opioid, according to the CDC. More than 130 people die each day from opioid-related drug overdoses, according to HHS, and nearly 80 percent of heroin users report misusing prescription…

The FDA warned StemGenex Biologic Laboratories about illegally marketing an unapproved stem cell product produced in a facility with significant manufacturing violations, putting patients at risk.